查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595321

製藥服務外包市場：按服務、按應用程式分類 - 2025-2030 年全球預測

Pharmaceutical Services Outsourcing Market by Service (Auditing & Assessment, Consulting, Product Design & Development), End-Use (Biotech, Pharma) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年醫藥服務外包市場規模為777.4億美元，預計2024年將達到832.3億美元，複合年成長率為7.54%，預計到2030年將達到1293.4億美元。

醫藥服務外包業務領域包括製劑、臨床試驗管理、監理諮詢等多種服務。該服務的定義是簡化業務的能力，使製藥公司能夠專注於其核心能力，同時利用外部專業知識來提高效率和成本效益。這種需求是由藥物開發日益複雜以及敏捷性和上市速度日益增加的競爭壓力所推動的。外包應用於藥物開發的各個階段，包括研發、臨床試驗和製造，最終用途範圍從生技公司到大型製藥企業。這個市場的關鍵成長因素包括藥物開發技術創新的不斷步伐、需要多樣化治療解決方案的慢性疾病數量的增加以及需要本地化專業知識的臨床試驗的全球化。近年來，隨著專業外包公司提供擴充性和先進技術力，個人化醫療和生技藥品領域的機會激增。為了抓住這些機會，公司應該投資與具有利基專業知識和適應性的公司建立策略夥伴關係。另一方面，應對不斷變化的監管環境、智慧財產權侵權風險和品管等挑戰仍然是困難的障礙。此外，COVID-19 大流行凸顯了物流和供應鏈的脆弱性，持續影響市場流動性。創新研究領域包括使用數位健康平台和人工智慧進行藥物發現分析，預計將提高效率和預測準確性。追求永續和環保的製造流程也提供了通往市場領導地位的先進道路。市場本質上是動態的，受到快速的技術進步和不斷變化的監管要求的推動，需要市場參與企業做出敏捷的反應和前瞻性的策略。平衡技術創新與強力的安全和合規措施對於駕馭這個不斷發展的生態系統至關重要。

主要市場統計
基準年[2023] 777.4億美元
預測年份 [2024] 832.3億美元
預測年份 [2030] 1293.4億美元
複合年成長率（%） 7.54%

市場動態：快速發展的醫藥服務外包市場的關鍵市場洞察

供需的動態交互作用正在改變醫藥服務外包市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 研發活動的醫藥支出增加
    • 生產和研究設施運作和管理中節省成本和時間所產生的潛在需求
    • 小型製藥和生物技術公司的需求不斷成長
  • 市場限制因素
    • 市場競爭加劇導致利潤率下降
  • 市場機會
    • 機器學習和人工智慧的興起以及藥物開發的自動化
    • 大規模投資再生醫學等新治療方法
  • 市場挑戰
    • 藥品品質缺乏一致性

波特五力：駕馭醫藥服務外包市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解醫藥服務外包市場的外部影響

外部宏觀環境因素在塑造醫藥服務外包市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解醫藥服務外包市場競爭狀況

醫藥服務外包市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 醫藥服務外包市場供應商定位矩陣績效評估

FPNV 定位矩陣是評估製藥服務外包市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製醫藥服務外包市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對製藥服務外包市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 增加研發活動的醫藥支出
      • 生產和研究設施運作和管理中節省成本和時間所產生的潛在需求
      • 中小型製藥公司和生技公司的需求增加
    • 抑制因素
      • 市場競爭激烈導致利潤率下降
    • 機會
      • 機器學習和人工智慧在藥物開發的介紹和自動化進展
      • 對再生醫學等新治療方法和治療方法的大量投資
    • 任務
      • 藥品品質缺乏一致性
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 醫藥服務外包市場：依服務分類

  • 審核與評估
  • 諮詢
  • 產品設計與開發
  • 產品維護
  • 產品測試和檢驗
  • 監管業務
  • 培訓和教育

第7章 醫藥服務外包市場：依最終用途分類

  • 生物技術
  • 製藥

第8章美洲醫藥服務外包市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太醫藥服務外包市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲/中東/非洲醫藥服務外包市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Cambrex Corporation
  • CareCloud, Inc.
  • Cerner Corporation
  • Charles River Laboratories International, Inc.
  • Concept Heidelberg GmbH
  • Eurofins Scientific SE
  • ICON PLC
  • Inspired Pharma Training Ltd.
  • IQVIA Inc.
  • Lachman Consultant Services, Inc.
  • NextGen Healthcare, Inc.
  • Parexel International Corporation
  • Reading Scientific Services Ltd.
  • SGS SA
  • The Quantic Group
Product Code: MRR-CA17E905E8BD

The Pharmaceutical Services Outsourcing Market was valued at USD 77.74 billion in 2023, expected to reach USD 83.23 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 129.34 billion by 2030.

The scope of pharmaceutical services outsourcing encompasses a variety of offerings that include drug formulation, clinical trial management, and regulatory consulting, among others. Defined by its capacity to streamline operations, it allows pharmaceutical companies to focus on core functions while leveraging expert external capabilities to enhance efficiency and cost-effectiveness. This necessity stems from the growing complexity of drug development and competitive pressures that demand agility and speed-to-market. Outsourcing is applied across various stages of drug development, including R&D, clinical trials, and manufacturing, with end-use sectors ranging from biotechnology firms to large pharmaceutical companies. Key growth factors fueling this market include the relentless pace of innovation in drug development, increasing prevalence of chronic diseases requiring diverse therapeutic solutions, and the globalization of clinical trials necessitating localized expertise. Lately, there are burgeoning opportunities in personalized medicine and biologics, where specialized outsourcing firms offer scalability and advanced technological capabilities. To capture these opportunities, companies should invest in strategic partnerships with firms possessing niche expertise and adaptive capacity. On the flip side, challenges such as compliance with ever-evolving regulatory landscapes, risks of intellectual property breaches, and quality control remain daunting hurdles. Furthermore, the COVID-19 pandemic underscored logistical and supply chain vulnerabilities that continue to impact market fluidity. Innovatively, the best areas for research lie in digital health platforms and AI-enhanced analytics for drug discovery, which promise to propel efficiency and predictive accuracy. Delving into sustainable and eco-friendly manufacturing processes also offers a progressive pathway for market leadership. The market is inherently dynamic, driven by rapid technological advancements and shifting regulatory demands, necessitating agile responses and forward-thinking strategies from market participants. Balancing innovation with robust safety and compliance measures will be essential in navigating this evolving ecosystem.

KEY MARKET STATISTICS
Base Year [2023] USD 77.74 billion
Estimated Year [2024] USD 83.23 billion
Forecast Year [2030] USD 129.34 billion
CAGR (%) 7.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Services Outsourcing Market

The Pharmaceutical Services Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing pharmaceutical expenditure on research and development activities
    • Potential need attributed to cost and time saving in operations and management of a production & research facility
    • Growing demand from small pharmaceuticals and biotechnology companies
  • Market Restraints
    • Reduced profit margins owing to robust competition in the market
  • Market Opportunities
    • Emerging adoption of machine learning and artificial intelligence coupled with automation in drug development
    • Extensive investment in novel and therapeutic therapies such as regenerative medicine
  • Market Challenges
    • Lack of consistency in the pharmaceutical product quality

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Services Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Services Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Services Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Services Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Services Outsourcing Market

A detailed market share analysis in the Pharmaceutical Services Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Services Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Services Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Services Outsourcing Market

A strategic analysis of the Pharmaceutical Services Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Services Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Cambrex Corporation, CareCloud, Inc., Cerner Corporation, Charles River Laboratories International, Inc., Concept Heidelberg GmbH, Eurofins Scientific SE, ICON PLC, Inspired Pharma Training Ltd., IQVIA Inc., Lachman Consultant Services, Inc., NextGen Healthcare, Inc., Parexel International Corporation, Reading Scientific Services Ltd., SGS SA, and The Quantic Group.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Services Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Auditing & Assessment, Consulting, Product Design & Development, Product Maintenance, Product Testing & Validation, Regulatory Affairs, and Training & Education.
  • Based on End-Use, market is studied across Biotech and Pharma.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing pharmaceutical expenditure on research and development activities
      • 5.1.1.2. Potential need attributed to cost and time saving in operations and management of a production & research facility
      • 5.1.1.3. Growing demand from small pharmaceuticals and biotechnology companies
    • 5.1.2. Restraints
      • 5.1.2.1. Reduced profit margins owing to robust competition in the market
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging adoption of machine learning and artificial intelligence coupled with automation in drug development
      • 5.1.3.2. Extensive investment in novel and therapeutic therapies such as regenerative medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of consistency in the pharmaceutical product quality
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pharmaceutical Services Outsourcing Market, by Service

  • 6.1. Introduction
  • 6.2. Auditing & Assessment
  • 6.3. Consulting
  • 6.4. Product Design & Development
  • 6.5. Product Maintenance
  • 6.6. Product Testing & Validation
  • 6.7. Regulatory Affairs
  • 6.8. Training & Education

7. Pharmaceutical Services Outsourcing Market, by End-Use

  • 7.1. Introduction
  • 7.2. Biotech
  • 7.3. Pharma

8. Americas Pharmaceutical Services Outsourcing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pharmaceutical Services Outsourcing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Pharmaceutical Services Outsourcing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cambrex Corporation
  • 2. CareCloud, Inc.
  • 3. Cerner Corporation
  • 4. Charles River Laboratories International, Inc.
  • 5. Concept Heidelberg GmbH
  • 6. Eurofins Scientific SE
  • 7. ICON PLC
  • 8. Inspired Pharma Training Ltd.
  • 9. IQVIA Inc.
  • 10. Lachman Consultant Services, Inc.
  • 11. NextGen Healthcare, Inc.
  • 12. Parexel International Corporation
  • 13. Reading Scientific Services Ltd.
  • 14. SGS SA
  • 15. The Quantic Group

LIST OF FIGURES

  • FIGURE 1. PHARMACEUTICAL SERVICES OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PHARMACEUTICAL SERVICES OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY AUDITING & ASSESSMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY CONSULTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT DESIGN & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT MAINTENANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PRODUCT TESTING & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY PHARMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM PHARMACEUTICAL SERVICES OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. PHARMACEUTICAL SERVICES OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. PHARMACEUTICAL SERVICES OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023